178 related articles for article (PubMed ID: 27835890)
1. Jumonji domain-containing protein 1A promotes cell growth and progression via transactivation of c-Myc expression and predicts a poor prognosis in cervical cancer.
Liu J; Zhu M; Xia X; Huang Y; Zhang Q; Wang X
Oncotarget; 2016 Dec; 7(51):85151-85162. PubMed ID: 27835890
[TBL] [Abstract][Full Text] [Related]
2. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.
Yang H; Liu Z; Yuan C; Zhao Y; Wang L; Hu J; Xie D; Wang L; Chen D
Int J Clin Exp Pathol; 2015; 8(9):11092-9. PubMed ID: 26617828
[TBL] [Abstract][Full Text] [Related]
3. The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1.
Tee AE; Ling D; Nelson C; Atmadibrata B; Dinger ME; Xu N; Mizukami T; Liu PY; Liu B; Cheung B; Pasquier E; Haber M; Norris MD; Suzuki T; Marshall GM; Liu T
Oncotarget; 2014 Apr; 5(7):1793-804. PubMed ID: 24742640
[TBL] [Abstract][Full Text] [Related]
4. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.
Fan L; Peng G; Sahgal N; Fazli L; Gleave M; Zhang Y; Hussain A; Qi J
Oncogene; 2016 May; 35(19):2441-52. PubMed ID: 26279298
[TBL] [Abstract][Full Text] [Related]
5. Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling.
Peng K; Su G; Ji J; Yang X; Miao M; Mo P; Li M; Xu J; Li W; Yu C
J Biol Chem; 2018 Jul; 293(27):10606-10619. PubMed ID: 29802196
[TBL] [Abstract][Full Text] [Related]
6. JMJD1A, H3K9me1, H3K9me2 and ADM expression as prognostic markers in oral and oropharyngeal squamous cell carcinoma.
Maia LL; Peterle GT; Dos Santos M; Trivilin LO; Mendes SO; de Oliveira MM; Dos Santos JG; Stur E; Agostini LP; Couto CVMDS; Dalbó J; de Assis ALEM; Archanjo AB; Mercante AMDC; Lopez RVM; Nunes FD; de Carvalho MB; Tajara EH; Louro ID; Álvares-da-Silva AM
PLoS One; 2018; 13(3):e0194884. PubMed ID: 29590186
[TBL] [Abstract][Full Text] [Related]
7. Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection.
Yamada D; Kobayashi S; Yamamoto H; Tomimaru Y; Noda T; Uemura M; Wada H; Marubashi S; Eguchi H; Tanemura M; Doki Y; Mori M; Nagano H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S355-64. PubMed ID: 21607773
[TBL] [Abstract][Full Text] [Related]
8. Histone demethylase Jumonji domain-containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt-related transcription factor 3.
Ning K; Shao Y; He Y; Wang F; Cui X; Liu F; Li D; Li F
Cancer Sci; 2020 Oct; 111(10):3679-3692. PubMed ID: 32762126
[TBL] [Abstract][Full Text] [Related]
9. Histone Demethylase JMJD1A Promotes Tumor Progression via Activating Snail in Prostate Cancer.
Tang DE; Dai Y; Xu SH
Mol Cancer Res; 2020 May; 18(5):698-708. PubMed ID: 32019811
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
12. JMJD1A promotes tumorigenesis and forms a feedback loop with EZH2/let-7c in NSCLC cells.
Zhan M; Wen F; Liu L; Chen Z; Wei H; Zhou H
Tumour Biol; 2016 Aug; 37(8):11237-47. PubMed ID: 26945572
[TBL] [Abstract][Full Text] [Related]
13. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase JMJD1A in cancer progression and therapeutic resistance.
Jeon HY; Ryu H; Pornour M; Qi J
Mol Carcinog; 2022 Apr; 61(4):392-396. PubMed ID: 35020958
[TBL] [Abstract][Full Text] [Related]
15. Low expression of long noncoding XLOC_010588 indicates a poor prognosis and promotes proliferation through upregulation of c-Myc in cervical cancer.
Liao LM; Sun XY; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M; Huang L
Gynecol Oncol; 2014 Jun; 133(3):616-23. PubMed ID: 24667250
[TBL] [Abstract][Full Text] [Related]
16. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
[TBL] [Abstract][Full Text] [Related]
17. FABP5 correlates with poor prognosis and promotes tumor cell growth and metastasis in cervical cancer.
Wang W; Chu HJ; Liang YC; Huang JM; Shang CL; Tan H; Liu D; Zhao YH; Liu TY; Yao SZ
Tumour Biol; 2016 Nov; 37(11):14873-14883. PubMed ID: 27644245
[TBL] [Abstract][Full Text] [Related]
18. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
Cao S; Liu W; Li F; Zhao W; Qin C
Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
[TBL] [Abstract][Full Text] [Related]
20. Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion.
Zhang X; Li F; Zhu PL
Biomed Pharmacother; 2016 Dec; 84():270-276. PubMed ID: 27665472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]